Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01277770 · ClinicalTrials.gov registry record

Studies of Kidney Transplant Outcome

A clinical trial of Transplant Recipient (Kidney) and Steroid-Free Maintenance Immunosuppression, sponsored by University of Minnesota.

Completed
Registry status
7,500
Enrollment target
1
Study location

NCT01277770: Completed study of Transplant Recipient (Kidney) and Steroid-Free Maintenance Immunosuppression, sponsored by University of Minnesota.

NCT01277770 is a study of Transplant Recipient (Kidney) and Steroid-Free Maintenance Immunosuppression that has completed, run by University of Minnesota. The registered enrollment target is 7,500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01277770, a study of Transplant Recipient (Kidney) and Steroid-Free Maintenance Immunosuppression, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
7,500 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to improve outcome for kidney transplant recipients. There has not been commensurate improvement in medium and long-term outcomes. Ongoing clinical research is necessary to improve transplant outcomes.

Primary Outcome

All studies are analyses from the Transplant Outcomes Database. Recipients have signed consent to have medical information entered into the database for these analyses. The database contains information on short, medium and long-term results.

Interventions

  • DRUG Steroid-Free Maintenance Immunosuppression
  • OTHER Infection After Kidney Transplantation
  • DRUG Evaluation of the DGF nomogram in Thymoglobulin

Study Locations (1)

Minnesota

  • University Of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 7,500 participants
Start Date 2009-05
Est. Completion 2019-05-06
University of Minnesota

966 total trials

What the finished NCT01277770 record still lists

NCT01277770 is an observational study that tracks outcomes without assigning an intervention. Its 7,500 participants enrollment target places it among the larger protocols in the corpus.

The record links to 4 conditions, with Transplant Recipient (Kidney) appearing as the primary indexed condition, and to 3 interventions - of which Steroid-Free Maintenance Immunosuppression is the first listed.

NCT01277770 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT01277770 about?

NCT01277770 is a clinical study titled "Studies of Kidney Transplant Outcome". The purpose of this study is to improve outcome for kidney transplant recipients. There has not been commensurate improvement in medium and long-term outcomes. Ongoing clinical research is necessary to improve transplant outcomes.

What is the current status of trial NCT01277770?

This trial is currently completed. The enrollment target is 7,500 participants. The study started on 2009-05. Estimated completion is 2019-05-06.

What conditions does trial NCT01277770 study?

This clinical trial studies the following conditions: Transplant Recipient (Kidney), Steroid-Free Maintenance Immunosuppression, Post-Transplant Infections, Thymoglobulin.

What interventions are being tested in trial NCT01277770?

The interventions under investigation include: Steroid-Free Maintenance Immunosuppression (DRUG), Infection After Kidney Transplantation (OTHER), Evaluation of the DGF nomogram in Thymoglobulin (DRUG).

Who is sponsoring clinical trial NCT01277770?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01277770 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Transplant Recipient (Kidney)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00439049 · 7,500 participants

    Substance Abuse Pre-Treatment Screening Study

  • NCT04809740 · 7,500 participants · NA

    Evaluating the Implementation and Impact of Navigator-delivered ePRO System

  • NCT05199701 · 7,500 participants · NA

    Prospective Case Collection Study for New Mammography Technologies

  • NCT06112418 · 7,500 participants · NA

    A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01277770, the US trial registry maintained by the National Library of Medicine. NCT01277770 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.